Price
CHART BY
Frequently asked questions
What is Calidi's market capitalization?
The market capitalization of Calidi is $25.63M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Calidi?
Calidi's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$5.809. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Calidi's stock?
Currently, 2 analysts cover Calidi's stock, with a consensus target price of $6.25. Analyst ratings provide insights into the stock's expected performance.
What is the EBITDA for Calidi?
Calidi's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$26.06M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Calidi?
Calidi has a free cash flow of -$19.54M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Calidi have, and what sector and industry does it belong to?
Calidi employs approximately 41 people. It operates in the Health Care sector, specifically within the Biotechnology industry.
What is the free float of Calidi's shares?
The free float of Calidi is 16.76M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $25.63M
- EPS (TTM)
- -$5.809
- Free Float
- 16.76M
- EBITDA (TTM)
- -$26.06M
- Free Cashflow (TTM)
- -$19.54M
Pricing
- 52W span
- $0.142$3.88
Analyst Ratings
The price target is $6.25 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.
- Employees
- 41
- Industries
- Biotechnology
- Sector
- Health Care
Identifier
- ISIN
- US3207033099
- Primary Ticker
- CLDI